Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD
CKD/ESRD-MIT
3 other identifiers
interventional
120
1 country
1
Brief Summary
Transitional care strategies focused on enhancing the accuracy and comprehensiveness of medication information transfer will lead to improved health outcomes among hospitalized patients with chronic kidney disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 24, 2011
CompletedFirst Posted
Study publicly available on registry
October 26, 2011
CompletedStudy Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedApril 6, 2017
April 1, 2017
4.1 years
October 24, 2011
April 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
acute care utilization
Acute care utilization defined by emergency department visits and hospitalizations in the first 30 and 90 days after discharge from the index hospitalization.
90 days
Secondary Outcomes (2)
CKD status, risk factors and complications
30 and 90 days
ESRD status, risk factors and complications:
30 and 90 days
Study Arms (2)
control
ACTIVE COMPARATORusual care for hospital discharge: 1. CKD group 2. ESRD group
intervention
ACTIVE COMPARATORpharmacist administered medication information transfer intervention 1. CKD group 2. ESRD group
Interventions
A pharmacist will visit participants randomized to the intervention group in their homes within 5 days of hospital discharge to administer the 5As Medication Self-Management intervention: Assessment, Advise, Agreement, Assistance, Arrangements.
Patients will receive medication information according to standard practice for discharge of hospitalized patients.
Eligibility Criteria
You may qualify if:
- Hospitalized patients
- \> 21 years of age
- Diagnosis of CKD stages 3-5, not treated by dialysis
- Hospitalized patients
- \> 21 years of age
- Patients treated with hemodialysis or peritoneal dialysis
You may not qualify if:
- \. Kidney Transplant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Providence Sacred Heart Medical Center & Children's Hospital
Spokane, Washington, 99204, United States
Related Publications (1)
Alicic RZ, Short RA, Corbett CL, Neumiller JJ, Gates BJ, Daratha KB, Barbosa-Leiker C, McPherson S, Chaytor NS, Dieter BP, Setter SM, Tuttle KR. Medication Intervention for Chronic Kidney Disease Patients Transitioning from Hospital to Home: Study Design and Baseline Characteristics. Am J Nephrol. 2016;44(2):122-9. doi: 10.1159/000447019. Epub 2016 Aug 4.
PMID: 27487357DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katherine R Tuttle, MD
Providence Sacred Heart Medical Center and Children's Hospital; University of Washington School of Medicine
- PRINCIPAL INVESTIGATOR
Cynthia L Corbett, PhD
Washington State University College of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 24, 2011
First Posted
October 26, 2011
Study Start
November 1, 2011
Primary Completion
December 1, 2015
Study Completion
April 1, 2016
Last Updated
April 6, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share